Clinical trial
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid…
NCT00467506 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00467506 |
|---|---|
| Title | Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma |
| Official title | Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma |
| Acronym | RIT in MTC |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thyroid Neoplasms |
| Intervention type | Drug |
| Interventions | bispecific antibody and di-DTPA-131I |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Apr 30, 2007 |
| Last update posted | Nov 11, 2011 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: